• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸机相关性肺炎的归因死亡率:应用因果分析的再评估。

Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis.

机构信息

Department of Applied Mathematics and Computer Sciences, Ghent University, Ghent, Belgium.

出版信息

Am J Respir Crit Care Med. 2011 Nov 15;184(10):1133-9. doi: 10.1164/rccm.201105-0867OC.

DOI:10.1164/rccm.201105-0867OC
PMID:21852541
Abstract

RATIONALE

Measuring the attributable mortality of ventilator-associated pneumonia (VAP) is challenging and prone to different forms of bias. Studies addressing this issue have produced variable and controversial results.

OBJECTIVES

We estimate the attributable mortality of VAP in a large multicenter cohort using statistical methods from the field of causal inference.

METHODS

Patients (n = 4,479) from the longitudinal prospective (1997-2008) French multicenter Outcomerea database were included if they stayed in the intensive care unit (ICU) for at least 2 days and received mechanical ventilation (MV) within 48 hours after ICU admission. A competing risk survival analysis, treating ICU discharge as a competing risk for ICU mortality, was conducted using a marginal structural modeling approach to adjust for time-varying confounding by disease severity.

MEASUREMENTS AND MAIN RESULTS

Six hundred eighty-five (15.3%) patients acquired at least one episode of VAP. We estimated that 4.4% (95% confidence interval, 1.6-7.0%) of the deaths in the ICU on Day 30 and 5.9% (95% confidence interval, 2.5-9.1%) on Day 60 are attributable to VAP. With an observed ICU mortality of 23.3% on Day 30 and 25.6% on Day 60, this corresponds to an ICU mortality attributable to VAP of about 1% on Day 30 and 1.5% on Day 60.

CONCLUSIONS

Our study on the attributable mortality of VAP is the first that simultaneously accounts for the time of acquiring VAP, informative loss to follow-up after ICU discharge, and the existence of complex feedback relations between VAP and the evolution of disease severity. In contrast to the majority of previous reports, we detected a relatively limited attributable ICU mortality of VAP.

摘要

背景

评估呼吸机相关性肺炎(VAP)的病死率具有挑战性,并且容易受到不同类型偏倚的影响。研究呼吸机相关性肺炎病死率的相关研究结果存在差异,颇具争议。

目的

我们使用因果推理领域的统计方法,从大型多中心队列中估计呼吸机相关性肺炎的病死率。

方法

我们纳入了纵向前瞻性(1997-2008 年)法国多中心 Outcomesrea 数据库中的患者(n=4479),这些患者入住重症监护病房(ICU)至少 2 天,并且在入住 ICU 后 48 小时内接受机械通气(MV)。采用边际结构模型方法进行竞争风险生存分析,将 ICU 出院视为 ICU 死亡率的竞争风险,以调整疾病严重程度的时变混杂因素。

测量和主要结果

685 例(15.3%)患者至少发生 1 次 VAP 。我们估计,第 30 天和第 60 天 ICU 死亡率归因于 VAP 的分别为 4.4%(95%置信区间,1.6-7.0%)和 5.9%(95%置信区间,2.5-9.1%)。在第 30 天和第 60 天观察到的 ICU 死亡率分别为 23.3%和 25.6%,这相当于第 30 天和第 60 天归因于 VAP 的 ICU 死亡率分别为 1%和 1.5%。

结论

我们的研究首次同时考虑了获得 VAP 的时间、ICU 出院后信息缺失随访以及 VAP 与疾病严重程度演变之间存在复杂反馈关系对 VAP 病死率归因的影响。与大多数先前的报告不同,我们发现 VAP 归因于 ICU 的死亡率相对有限。

相似文献

1
Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis.呼吸机相关性肺炎的归因死亡率:应用因果分析的再评估。
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1133-9. doi: 10.1164/rccm.201105-0867OC.
2
Attributable mortality of ventilator-associated pneumonia: a meta-analysis.呼吸机相关性肺炎的归因死亡率:一项荟萃分析。
Int J Tuberc Lung Dis. 2011 Sep;15(9):1154-63, i-v. doi: 10.5588/ijtld.10.0498. Epub 2011 Jun 8.
3
Impact of intensive-care-unit(ICU)-acquired ventilator-associated pneumonia(VAP) on hospital mortality: a matched-paired case-control study.重症监护病房(ICU)获得性呼吸机相关性肺炎(VAP)对医院死亡率的影响:一项配对病例对照研究。
Nagoya J Med Sci. 2007 Jan;69(1-2):29-36.
4
Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.呼吸机相关性肺炎患者感染复发和死亡的早期预测因素
Crit Care Med. 2007 Jan;35(1):146-54. doi: 10.1097/01.CCM.0000249826.81273.E4.
5
Hospital and long-term outcomes of ICU-treated severe community- and hospital-acquired, and ventilator-associated pneumonia patients.重症监护病房治疗的严重社区获得性、医院获得性和呼吸机相关性肺炎患者的住院和长期结局。
Acta Anaesthesiol Scand. 2011 Nov;55(10):1254-60. doi: 10.1111/j.1399-6576.2011.02535.x. Epub 2011 Sep 27.
6
Late-onset ventilator-associated pneumonia in nontrauma intensive care unit patients.非创伤性重症监护病房患者的迟发性呼吸机相关性肺炎
Anesth Analg. 2009 Nov;109(5):1584-90. doi: 10.1213/ANE.0b013e3181b6e9b6. Epub 2009 Aug 27.
7
Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.诗里拉吉医院成人医院获得性肺炎和呼吸机相关性肺炎:病因、临床结局及抗菌药物耐药性的影响
J Med Assoc Thai. 2010 Jan;93 Suppl 1:S126-38.
8
Nosocomial pneumonia in the ICU: a prospective cohort study.重症监护病房中的医院获得性肺炎:一项前瞻性队列研究。
Scand J Infect Dis. 2007;39(8):676-82. doi: 10.1080/00365540701225728.
9
The impact of COPD on ICU mortality in patients with ventilator-associated pneumonia.慢性阻塞性肺疾病对呼吸机相关性肺炎患者 ICU 死亡率的影响。
Respir Med. 2011 Jul;105(7):1022-9. doi: 10.1016/j.rmed.2011.03.001. Epub 2011 Mar 24.
10
Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models.呼吸机相关性肺炎的归因死亡率:使用条件逻辑回归和多状态模型分析 ICU 入院和 VAP 发病时主要特征的各自影响。
Intensive Care Med. 2010 May;36(5):781-9. doi: 10.1007/s00134-010-1824-6. Epub 2010 Mar 16.

引用本文的文献

1
Epidemiology and prediction of non-targeted bacteria by the filmarray pneumonia plus panel in culture-positive ventilator-associated pneumonia: a retrospective multicentre analysis.FilmArray肺炎加检测板对培养阳性的呼吸机相关性肺炎中非目标细菌的流行病学及预测:一项回顾性多中心分析
Ann Intensive Care. 2025 Apr 28;15(1):57. doi: 10.1186/s13613-025-01468-6.
2
Ten-Year Evaluation of Ventilator-Associated Pneumonia (VAP) According to Initial Empiric Treatment: A Retrospective Analysis Using Real-World Data.根据初始经验性治疗对呼吸机相关性肺炎(VAP)的十年评估:一项使用真实世界数据的回顾性分析
Biomedicines. 2025 Feb 5;13(2):360. doi: 10.3390/biomedicines13020360.
3
Factors Associated with Mortality in Nosocomial Lower Respiratory Tract Infections: An ENIRRI Analysis.
医院获得性下呼吸道感染死亡率的相关因素:一项ENIRRI分析
Antibiotics (Basel). 2025 Jan 26;14(2):127. doi: 10.3390/antibiotics14020127.
4
Clinical impact of healthcare-associated infections in Brazilian ICUs: a multicenter prospective cohort.巴西重症监护病房中医疗保健相关感染的临床影响:一项多中心前瞻性队列研究
Crit Care. 2025 Jan 3;29(1):4. doi: 10.1186/s13054-024-05203-8.
5
Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy.革兰氏阴性杆菌引起的菌血症性医院获得性肺炎:意大利全国性ALARICO研究的结果
Infection. 2024 Dec 6. doi: 10.1007/s15010-024-02423-6.
6
Clinical outcomes of antifungal therapy on Candida pulmonary colonisation in immunocompetent patients with invasive ventilation: a systematic review and meta-analysis.免疫功能正常的侵袭性通气患者中抗真菌治疗对假丝酵母菌肺部定植的临床结局:系统评价和荟萃分析。
BMJ Open. 2024 Oct 22;14(10):e083918. doi: 10.1136/bmjopen-2024-083918.
7
Improving Outcomes in Nosocomial Pneumonia: Recent Evidence and More Challenges.改善医院获得性肺炎的治疗效果:最新证据与更多挑战
Pathogens. 2024 Jun 10;13(6):495. doi: 10.3390/pathogens13060495.
8
Nomogram to predict ventilator-associated pneumonia in large vessel occlusion stroke after endovascular treatment: a retrospective study.预测血管内治疗后大血管闭塞性卒中患者呼吸机相关性肺炎的列线图:一项回顾性研究
Front Neurol. 2024 May 13;15:1351458. doi: 10.3389/fneur.2024.1351458. eCollection 2024.
9
Rebound Inverts the Bacteremia Prevention Effect of Antibiotic Based Decontamination Interventions in ICU Cohorts with Prolonged Length of Stay.在住院时间延长的重症监护病房队列中,反弹逆转了基于抗生素去污干预措施预防菌血症的效果。
Antibiotics (Basel). 2024 Mar 29;13(4):316. doi: 10.3390/antibiotics13040316.
10
Epidemiology and Burden of Ventilator-Associated Pneumonia among Adult Intensive Care Unit Patients: A Portuguese, Multicenter, Retrospective Study (eVAP-PT Study).成人重症监护病房患者呼吸机相关性肺炎的流行病学与负担:一项葡萄牙多中心回顾性研究(eVAP-PT研究)
Antibiotics (Basel). 2024 Mar 22;13(4):290. doi: 10.3390/antibiotics13040290.